CAT No: CP25470
CAS No: 174132-31-1
Synonyms/Alias: 174132-31-1;FMOC-P(NH-BOC)-L-PHE-OH;(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(4-((tert-butoxycarbonyl)amino)phenyl)propanoic acid;Fmoc-Phe(4-NHBoc)-OH;Fmoc-4-(Boc-amino)-L-phenylalanine;CID 2756117;(2S)-2-(9H-fluoren-9-ylmethoxycarbonylamino)-3-[4-[(2-methylpropan-2-yl)oxycarbonylamino]phenyl]propanoic acid;L-Phenylalanine, 4-[[(1,1-dimethylethoxy)carbonyl]amino]-N-[(9H-fluoren-9-ylmethoxy)carbonyl]-;4-(Boc-amino)-N-Fmoc-L-phenylalanine;Fmoc-L-4-aminophe(Boc);Fmoc-L-Phe(4-NHBoc)-OH;MFCD00237007;(2S)-3-{4-[(tert-butoxycarbonyl)amino]phenyl}-2-{[(9H-fluoren-9-ylmethoxy)carbonyl]amino}propanoic acid;(s)-2-(((9h-fluoren-9-yl)methoxy)carbonylamino)-3-(4-(tert-butoxycarbonylamino)phenyl)propanoic acid;Fmoc-p-amino-Phe(Boc)-OH;KVUAOWDVYMUKPE-VWLOTQADSA-N;(s)-fmoc-(4-boc-amino)phenylalanine;SCHEMBL3728072;DTXSID20938472;AKOS024258530;CS-W013824;FF47785;HY-W013108;DA-53353;DS-15271;F12305;Fmoc-L-Phe(4-NHBoc)-OH;(S)-Fmoc-2-amino-3-(4-Boc-aminophenyl)propionic acid;(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(4-((tert-butoxycarbonyl)amino)phenyl)propanoicacid;4-[(tert-Butoxycarbonyl)amino]-N-{[(9H-fluoren-9-yl)methoxy](hydroxy)methylidene}phenylalanine;N-alpha-(9-Fluorenylmethyloxycarbonyl)-4-t-butyloxycarbonylamino-L-phenylalanine (Fmoc-L-Phe(4-NHBoc)-OH);
Chemical Name: N-alpha-(9-Fluorenylmethyloxycarbonyl)-4-t-butyloxycarbonylamino-L-phenylalanine
Quick InquiryCustom Peptide SynthesisPeptide Library Construction and Screening
Powerful screening tools in biological and chemical research
M.F/Formula | C29H30N2O6 |
M.W/Mr. | 502.6 |
Size | 1 g;5 g;25 g; |
InChI | InChI=1S/C29H30N2O6/c1-29(2,3)37-28(35)30-19-14-12-18(13-15-19)16-25(26(32)33)31-27(34)36-17-24-22-10-6-4-8-20(22)21-9-5-7-11-23(21)24/h4-15,24-25H,16-17H2,1-3H3,(H,30,35)(H,31,34)(H,32,33)/t25-/m0/s1 |
InChI Key | KVUAOWDVYMUKPE-VWLOTQADSA-N |
Canonical SMILES | CC(C)(C)OC(=O)NC1=CC=C(C=C1)CC(C(=O)O)NC(=O)OCC2C3=CC=CC=C3C4=CC=CC=C24 |
4. Low bone turnover and low BMD in Down syndrome: effect of intermittent PTH treatment
5. Urinary Metabolites Associated with Blood Pressure on a Low-or High-Sodium Die
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at info@creative-peptides.com. We will endeavor to provide highly satisfying products and services.